Search
(c) SAM, CHUV
Department of Oncology
Last news
Targeting turncoat immune cells to treat cancer
Research led by Ping-Chih Ho of the Ludwig Lausanne branch has identified a mechanism by which regulatory T cells adapt their metabolism to thrive in the harsh microenvironment of the tumor.
Research led by Ping-Chih Ho of the Ludwig Lausanne branch has identified a mechanism by which regulatory T cells adapt their metabolism to thrive in the harsh microenvironment of the tumor.
Countering therapy resistance in colorectal cancer
A new treatment modality for colorectal cancers that do not respond to standard chemotherapy has been identified by Tatiana Petrova of the Lausanne Branch of the Ludwig Institute for Cancer Research and Michele De Palma of the EPFL.
A new treatment modality for colorectal cancers that do not respond to standard chemotherapy has been identified by Tatiana Petrova of the Lausanne Branch of the Ludwig Institute for Cancer Research and Michele De Palma of the EPFL.
Building a safer CAR-T therapy
A new type of chimeric antigen-receptor (CAR) T cell that can be switched on and off on demand is unveiled in a study led by Melita Irving and George Coukos, both of the Lausanne Branch of the Ludwig Institute for Cancer Research, and Bruno Correia of the EPFL.
A new type of chimeric antigen-receptor (CAR) T cell that can be switched on and off on demand is unveiled in a study led by Melita Irving and George Coukos, both of the Lausanne Branch of the Ludwig Institute for Cancer Research, and Bruno Correia of the EPFL.
Events
